250
Participants
Start Date
September 17, 2020
Primary Completion Date
December 12, 2022
Study Completion Date
February 6, 2023
MEDI3506
Participants will receive multiple doses of MEDI3506 at dose level 1 or dose level 2
Placebo
Participants will receive multiple doses of placebo
Research Site, Budapest
Research Site, Benoni
Research Site, San Juan Bautista
Research Site, Gödöllő
Research Site, Johannesburg
Research Site, Százhalombatta
Research Site, Balassagyarmat
Research Site, San Miguel de Tucumán
Research Site, Durban
Research Site, Durban
Research Site, Mendoza
Research Site, Godoy Cruz
Research Site, Szeged
Research Site, Cape Town
Research Site, Bellville
Research Site, Cape Town
Research Site, Mar del Plata
Research Site, Cape Town
Research Site, Bloemfontein
Research Site, Welkom
Research Site, Berlin
Research Site, Schwerin
Research Site, Bychawa
Research Site, Lübeck
Research Site, Peine
Research Site, Coral Gables
Research Site, Magdeburg
Research Site, Toledo
Research Site, Mainz
Research Site, Koblenz
Research Site, Missoula
Research Site, Frankfurt am Main
Research Site, Frankfurt
Research Site, Edmond
Research Site, Boerne
Research Site, Landsberg
Research Site, Los Angeles
Research Site, Newport Beach
Research Site, Bakersfield
Research Site, Ames
Research Site, Buenos Aires
Research Site, Buenos Aires
Research Site, CABA
Research Site, Córdoba
Research Site, Florida
Research Site, Lanús Este
Research Site, Mendoza
Research Site, Quilmes
Research Site, Cottbus
Research Site, Leipzig
Research Site, Bialystok
Research Site, Bydgoszcz
Research Site, Katowice
Research Site, Krakow
Research Site, Lodz
Research Site, Lublin
Research Site, Poznan
Research Site, Tarnów
Research Site, Wroclaw
Research Site, Wroclaw
Research Site, Pretoria
Research Site, Bradford
Research Site, Cambridge
Research Site, High Wycombe
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY